
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations is expected to achieve strong revenue growth in FY26 with increased expenses, but these expenses are expected to decrease in 4Q26. With new technology and robotic offerings coming in 1H27 and a new product, InSet Clutch, expected to raise prices, there is potential for further revenue growth. However, slower uptake by new surgeons and higher expenses may pose risks. Yet, strong Q2 results, a strong product pipeline, and a lower EV/Sales ratio make it a promising investment with a proposed target price of $26.
Bears say
Shoulder Innovations is a commercial-stage medical technology company with potential for growth in its addressable market and a strong pipeline of new products. However, the company faces risks such as increased competition in the robotics market and supply chain challenges. Its current valuation is lower than its peers, but the company's growth profile and portfolio of catalysts could warrant a higher valuation premium.
This aggregate rating is based on analysts' research of Shoulder Innovations LLC and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares